Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy

Cell Res. 2017 Jan;27(1):151-153. doi: 10.1038/cr.2016.102. Epub 2016 Aug 30.

Kefang Liu^{1

2}, Shuguang Tan³, Yan Chai³, Danqing Chen³, Hao Song⁴, Catherine Wei-Hong Zhang⁵, Yi Shi³, Jun Liu^{1

2}, Wenjie Tan^{1

2}, Jianxin Lyu¹, Shan Gao⁶, Jinghua Yan⁷, Jianxun Qi³, George F Gao^{1

2

3}

¹ College of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
² National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
³ CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
⁴ Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing 100101, China.
⁵ ImmuFucell Biotechnology Co., Ltd., Beijing 100102, China.
⁶ CAS Key Laboratory of Bio-medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, China.
⁷ CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

No abstract available

Publication types